1. Home
  2. SQNS vs CTMX Comparison

SQNS vs CTMX Comparison

Compare SQNS & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sequans Communications S.A.

SQNS

Sequans Communications S.A.

HOLD

Current Price

$2.42

Market Cap

48.0M

Sector

Technology

ML Signal

HOLD

Logo CytomX Therapeutics Inc.

CTMX

CytomX Therapeutics Inc.

HOLD

Current Price

$4.55

Market Cap

977.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SQNS
CTMX
Founded
2003
2008
Country
France
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
48.0M
977.1M
IPO Year
2011
2015

Fundamental Metrics

Financial Performance
Metric
SQNS
CTMX
Price
$2.42
$4.55
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
10
Target Price
$20.33
$12.10
AVG Volume (30 Days)
74.1K
10.2M
Earning Date
05-05-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$76,201,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$62.85
$27.22
P/E Ratio
N/A
$22.58
Revenue Growth
N/A
N/A
52 Week Low
$0.73
$0.40
52 Week High
$10.93
$8.21

Technical Indicators

Market Signals
Indicator
SQNS
CTMX
Relative Strength Index (RSI) 31.27 45.92
Support Level $1.23 $3.63
Resistance Level $3.27 $6.20
Average True Range (ATR) 0.15 0.61
MACD -0.03 -0.00
Stochastic Oscillator 6.45 10.05

Price Performance

Historical Comparison
SQNS
CTMX

About SQNS Sequans Communications S.A.

Sequans Communications SA is a designer, developer, and supplier of cellular semiconductor solutions for broadband Internet of Things (IoT) markets. Its offer 5G/4G chips and modules fully optimized for non-smartphone devices. The company covers applications such as smart mobility and logistics, smart utility meters, smart cities, smart industries, e-health and wellness, and smart homes to name few. The Company has one operating segment, which is the design and marketing of semiconductor components for cellular wireless systems. Its geographical segments are Taiwan, Korea, China (including Hong Kong), the Rest of Asia, the United States and the Rest of the world.

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Share on Social Networks: